| Literature DB >> 35795801 |
Douglas P Terry1, Fionn Büttner2,3, Nathan A Huebschmann4, Andrew J Gardner5, Nathan E Cook6,7,8, Grant L Iverson6,7,8,9.
Abstract
Background: Individuals with migraine disorders may be affected differently by concussions compared to individuals without migraine disorders. Prior studies on this topic have had mixed results. The purpose of this study was to systematically examine clinical outcomes following a sport-related concussion in athletes who have a pre-injury history of migraines.Entities:
Keywords: concussion; migraine; prolonged recovery; sport-related concussion; systematic review; traumatic brain injury
Year: 2022 PMID: 35795801 PMCID: PMC9251462 DOI: 10.3389/fneur.2022.915357
Source DB: PubMed Journal: Front Neurol ISSN: 1664-2295 Impact factor: 4.086
Figure 1Systematic Literature Search (PRISMA).
Study characteristics.
|
|
|
|
|
|
|---|---|---|---|---|
| Aggarwal (2017) 29058480 | Retrospective observational cohort study | No | Until recovery M = 28 days; Md = 17 days | |
| Beauchamp (2019) 31050335 | Longitudinal, prospective cohort study | No | 4 weeks / 12 weeks | |
| Eagle (2020) 32330895 | Retrospective cohort study (chart review); (80% with sport-related concussions) | Yes | 30 days (recovery variable) | |
| Eisenberg (2013) 23753087 | Prospective cohort study (64% with sport-related concussions) | No | 90 days | |
| Ellis (2015) 26359916 | Retrospective cohort study | No | 1 month+ | |
| Fehr (2019) 29084034 | Retrospective cohort study (chart review) | No | Md = 40 days (M = 62, SD = 64) | |
| Hiploylee (2017) 27784191 | Retrospective cohort study, with questionnaire follow-up | No | Years | |
| Howell (2016) 27230721 | Retrospective cohort study | Yes and No | 28 days | |
| Howell (2018) 30265817 | Retrospective cohort study | No | 28 days | |
| Findings: 19% of those with pre-injury migraines had a prolonged recovery, compared to 9% of those without a history of migraines. This was not significant in univariable analyses ( | ||||
| Howell (2019) 30994475 | Prospective cohort study | No | Until recovery (Md = 23 days, IQR = 16–32) | |
| Kontos (2019) 31479086 | Prospective cohort study | Yes | Until recovery (M = 27.5 days, SD = 25 days) | |
| Kontos (2020) 31904763 | Retrospective cohort study | No | Until recovery (M = 57 days, SD = 56, range = 9–299) | |
| Lau (2011) 21285444 | Prospective cohort study | No | 14 days (RTP variable) | |
| Lau (2011) 21712482 | Prospective cohort study | No | Until recovery (mean = 13 days, SD = 9 days) | |
| Lau (2012) | Prospective cohort study | No | 14 days cutoff (RTP variable) | |
| McDevitt (2015) | Case series study (i.e., prospective cohort) | No | Many months | |
| Meehan (2013) | Prospective cohort study | No | 28 days | |
| Meehan (2014) | Prospective cohort | No | 28 days | |
| Meehan (2016) | Prospective cohort | No | 28 days | |
| Miller (2016) | Case-control study (2 subgroups analyzed separately) | No | 28 days | |
| Morgan (2015) | Retrospective case-control study | No | PCS diagnosis made at 3 months | |
| Neidecker (2021) | Retrospective cohort study (chart review) | No | 5 days for boys and 7 days for girls | |
| Nelson (2016) | Prospective cohort study | No | Approximately 1 week for most patients; follow-up continued to 45 days | |
| Popovich (2021) | Retrospective cohort study | No | Return to play (several weeks) | |
| Sinnott (2019) | Prospective cohort study | Yes | 11–21 days | |
| Terry (2019) | Prospective cohort study | Yes And No | Return to school, Md = 5, IQR = 2–9, Range = 0–168 | |
| Zemek (2016) | Multicenter prospective cohort study | Yes | 28 days |
IQR, Interquartile Range; M, mean; Md, Median; NR, not reported; PCS, Post-Concussion Syndrome/Post-Concussion Symptoms; RTP, return to play; SD, standard deviation. The four Lau studies appeared to use the same sample and completed very similar analyses.
Methodological review related to pre-injury migraines and concussion outcome.
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Aggarwal (2017), 29058480 | Personal and family migraine history; method unclear | 9 | NR | Yes | NR | NR | Combined | Note A | Yes |
| Beauchamp (2019), 31050335 | Parent Report | 39 | NR | Yes | NR | NR | NR | NR | Somewhat |
| Eagle (2020), 32330895 | Self-reported history of headache or migraine | 82 | NR | No | NR | NR | NR | – | Somewhat |
| Eisenberg (2013), 23753087 | Personal & family migraine history: self-report with optional parental assistance ( | 29 | NR | Yes | NR | NR | Yes | Note B | No |
| Ellis (2015), 26359916 | Medical records: retrospective chart review | 16 | NR | NR | NR | NR | NR | – | No |
| Fehr (2019), 29084034 | Medical records: retrospective chart review | 53 | NR | NR | NR | NR | NR | – | No |
| Hiploylee (2017), 27784191 | Self-report | NR | NR | Yes | NR | NR | NR | – | No |
| Howell (2016), 27230721 | Self-report | Ages 8–12: 7 | NR | Yes | NR | NR | NR | – | Somewhat |
| Howell (2018), 30265817 | Self-report of physician-diagnosed migraines | 29 | NR | Yes | NR | NR | NR | – | Yes |
| Howell (2019), 30994475 | Headache or migraine | 96 | NR | No | NR | NR | NR | – | Somewhat |
| Kontos (2019), 31479086 | Self-report of medical diagnosis of migraine | 41 | NR | Yes | NR | NR | NR | – | Somewhat |
| Kontos (2020), 31904763 | Self-report during standardized clinical interview | 57 | NR | Yes | NR | NR | NR | – | No |
| Lau (2011), 21285444 | Self-report | 11 | NR | Yes | NR | NR | NR | – | No |
| Lau (2011), 21712482 | Self-report | 11 | NR | Yes | NR | NR | NR | – | No |
| Lau (2012), 21841522 | Self-report | 11 | NR | Yes | NR | NR | NR | – | No |
| McDevitt (2015), 26502998 | Self-report on a standardized initial evaluation | 10 | NR | NR | NR | NR | NR | – | No |
| Meehan (2013), 23628374 | Self-report | 19 | NR | Yes | NR | NR | NR | – | No |
| Meehan (2014), 25381296 | Self-report | 42 | NR | Yes | NR | NR | NR | – | Somewhat |
| Meehan (2016), 26718812 | Self-report intake forms | 4 | NR | Yes | NR | NR | NR | – | Somewhat |
| Miller (2016), 26684762 | Retrospective self and family report | With SCAT 2: 8 | NR | Yes | NR | NR | NR | – | No |
| Morgan (2015), 25745949 | Electronic medical records and a health history form | 15 | NR | Yes | NR | NR | Yes | Note C | No |
| Neidecker (2021), 33512393 | Electronic medical record review | 57 | NR | No; | NR | NR | NR | – | No |
| Nelson (2016), 27164666 | Baseline and postinjury clinical exams, which consisted of heath history | 8, [6.5% of sample, | NR | Yes | NR | NR | NR | – | No |
| Popovich (2021), 30768444 | Electronic medical record review | 25 | NR | Yes | NR | NR | NR | – | No |
| Sinnott (2019), 31521485 | Clinical interview | 8 | NR | Yes | NR | NR | NR | – | No |
| Terry (2019), 29732944 | Self-Report to Athletic Trainer | 117 | NR | Yes | NR | NR | NR | – | Yes |
| Zemek (2016), 26954410 | Physician diagnosed preinjury history of Migraine based on parent/child self-report | Derivation = 204 | NR | Yes | NR | NR | Yes | Note E | Somewhat |
Migraine Frequency refers to number of migraines in past month or year. Migraines clearly differentiated means that they are clearly differentiated from other headache disorders. Part of the hypotheses “Somewhat” means that it was combined with other variables. Note A: Family history and personal history of migraine were combined. Note B: Family history of migraine (n = 91) not significantly associated with outcome (p = 0.62). Note C: Development of PCS was associated with a family history of migraine (p = 0.003). 35% of the PCS group had a family history of migraines, while 11.3% of the control group had a family history of migraines. Note D: “Migraines or frequent headaches”. Note E: Family history of migraine Deviation n = 931 (Validation n = 505) was not a significant predictor of symptoms at 28 days (p = 0.08). ED, Emergency Department; ImPACT, Immediate Post-Concussion Assessment and Cognitive Testing; Md, Median; NR, Not Reported; OR, Odds Ratio; PCS, Post-Concussion Syndrome/Post-Concussion Symptoms; HR, Hazard Ratio; RPSQ, Rivermead Post-Concussion Symptom Questionnaire; SCAT, Sport Concussion Assessment Tool.
Risk of bias, as rated by the Quality in Prognostic Studies (QUIPS), and oxford centre for evidence-based medicine level of evidence.
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
| Aggarwal (2017) | Low | Moderate | Moderate | Moderate | Moderate | Moderate | Moderate | 3 |
| Beauchamp (2019) | Low | Moderate | Moderate | Low | Low | Moderate | Moderate | 3 |
| Eagle (2020) | Moderate | Moderate | High | Moderate | Moderate | Moderate | Moderate | 3 |
| Eisenberg (2013) | Low | Moderate | Moderate | Moderate | High | Moderate | Moderate | 3 |
| Ellis (2015) | Moderate | Moderate | Moderate | Moderate | Moderate | Moderate | Moderate | 3 |
| Fehr (2019) | Moderate | Moderate | Moderate | Moderate | Moderate | Moderate | Moderate | 3 |
| Hiploylee (2017) | High | High | Moderate | High | Moderate | Moderate | High | 3 |
| Howell (2016) | Moderate | Moderate | Moderate | Low | Moderate | Low | Moderate | 3 |
| Howell (2018) | Moderate | High | Moderate | Moderate | Moderate | Low | Moderate | 3 |
| Howell (2019) | Moderate | Moderate | Moderate | Moderate | Moderate | Moderate | Moderate | 3 |
| Kontos (2019) | Moderate | Low | Moderate | Low | Low | Low | Low | 3 |
| Kontos (2020) | Moderate | High | Moderate | Moderate | Moderate | Moderate | Moderate | 3 |
| Lau (2011) | Moderate | Moderate | Moderate | Low | Moderate | Moderate | Moderate | 3 |
| Lau (2011) | 3 | |||||||
| Lau (2012) | 3 | |||||||
| McDevitt (2015) | Moderate | Moderate | Moderate | Moderate | Moderate | Moderate | Moderate | 4 |
| Meehan (2013) | Moderate | Moderate | Moderate | Low | Moderate | Low | Moderate | 3 |
| Meehan (2014) | Moderate | Moderate | Moderate | Low | Moderate | Low | Moderate | 3 |
| Meehan (2016) | Moderate | Low | Moderate | Low | Moderate | Low | Moderate | 3 |
| Miller (2016) | Moderate | High | Moderate | Low | Moderate | Moderate | Moderate | 4 |
| Morgan (2015) | Low | Moderate | Moderate | Moderate | Moderate | Low | Moderate | 4 |
| Neidecker (2021) | Moderate | High | High | Moderate | Moderate | High | High | 3 |
| Nelson (2016) | Low | Low | Moderate | Moderate | Moderate | Low | Moderate | 3 |
| Popovich (2021) | Moderate | Moderate | Moderate | Moderate | Low | Moderate | Moderate | 3 |
| Sinnott (2019) | Moderate | Moderate | Moderate | Moderate | Moderate | Moderate | Moderate | 3 |
| Terry (2018) | Low | Moderate | Moderate | Moderate | Moderate | Low | Moderate | 3 |
| Zemek (2016) | Low | Low | Moderate | Low | Moderate | Low | Low | 3 |
LOE = Level of Evidence; OCEBM = Oxford Centre for Evidence-Based Medicine.
Likelihood ratio estimates.
|
| ||||
|---|---|---|---|---|
|
|
|
|
| |
| All Studies | 25 | 6 | 429,001, null favored | 1.66, null favored |
| Studies with Pre-Injury Migraine | 14 | 5 | 1.17, null favored | 1.16, alternative favored |
| Studies with Pre-Injury Migraine | 7 | 3 | 8.05, alternative favored | 1.69, alternative favored |
“Positive” refers to at least one statistically significant result (i.e., p ≤ 0.05). .